Charity registration number: 1157796
Newbury Cancer Care
Annual Report and Financial Statements for the Year Ended 31 December 2024
Newbury Cancer Care
| Contents | ||
|---|---|---|
| Reference and Administrative Details | 1 to 2 | |
| Trustees' Report | 3 to 7 | |
| Statement of Trustees' Responsibilities | 8 | |
| Independent Examiner's Report | 9 | |
| Statement of Financial Activities | 10 to 11 | |
| Balance Sheet | 12 | |
| Notes to the Financial Statements | 13 to 23 |
Newbury Cancer Care
Reference and Administrative Details
Chairman
D I Ormrod
Trustees :
==> picture [296 x 75] intentionally omitted <==
A J Cole
D I Ormrod
P L Wright K A De Monte (resigned 29 April 2024) J Baggaley (resigned 15 October 2024) T Allum (resigned 7 October 2025)
E J Allen
M C Bull
C Hunt (appointed 6 February 2024) R Knowles A Gold (appointed 4 June 2024) J Campbell (appointed 10 December 2024) V Beckwith (appointed 19 August 2025) R Mearkle (appointed 7 October 2025)
Senior Management / Leadership Team
==> picture [296 x 38] intentionally omitted <==
Dr Paul Millard, President Helen Milroy, Co-opted Member and Director of Operations
Charity Registration Number
1157796 Principal Office
==> picture [296 x 68] intentionally omitted <==
The Rosemary Centre West Berkshire Community Hospital Benham Hill Newbury Berkshire RG18 3AS
Independent Examiner
Kerry Hawkins FCCA UHY Ross Brooke Chartered Accountants and Registered Auditors 31a Charnham Street Hungerford Berkshire RG17 0EJ
Page 1
Newbury Cancer Care
Reference and Administrative Details (continued)
Solicitors
Gardner Leader LLP 20-24 Market Place Newbury Berkshire RG14 5BA Bankers
Newbury Building Society Lloyds Bank 2 Pavement York YO1 9UP
Page 2
Newbury Cancer Care
Trustees' Report
The trustees present the annual report together with the financial statements of the charity for the year ended 31 December 2024.
Objectives and activities
Objects and aims
Newbury Cancer Care was established more than 40 years ago to respond quickly and effectively to local (West Berkshire) needs by providing practical and emotional support to cancer patients and their families from diagnosis through to palliative and end of life care. The Charity also supports some other patients with life limiting illnesses. These remain our core objectives.
Public benefit
The Trustees have considered the Charity Commission's general guidance on public benefit and are satisfied that the Charity's aims and objectives and overall activities in serving the local community are compliant and conform with statutory requirements.
The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales.
Reserves and grant making policies
These are clearly related. There is a steady flow of requests to support/assist individuals who are experiencing financial hardship as a consequence of their cancer and each request for a financial grant is considered sympathetically and approved when considered appropriate. The Charity continues to support patient services and capital projects at the West Berkshire Hospital as funds allow.
The reserves policy is based upon the Charity's core objectives and its principal features are:
a. To achieve a margin of working capital sufficient to enable all aspects of the charity's activities to be conducted efficiently and unimpeded.
b. To provide sufficient resources to cover unexpected or unavoidable expenditure that cannot otherwise be met from income.
Total unrestricted reserves are considered sufficient to cover one year of routine fixed expenditure and allow the charity to continue to fulfil its core objectives.
Page 3
Newbury Cancer Care
Trustees' Report (continued)
Achievements and performance
Our transport services remain a core element of our operations. Demand remains high, with over 850 bookings to 10 healthcare locations for 126 patients. We have been successful in increasing our pool of volunteer drivers to 30, and they drove almost 50,000 miles to reduce patient stress whilst attending consultations and treatment appointments.
Somewhat surprisingly, our awards of hardship grants decreased from the 2023 levels, but the £34k awarded still represents a lifeline for many people struggling financially through their cancer treatments.
Demand for the annual calendars, featuring local scenes and landscapes, has declined over recent years. The effort to produce and distribute them now outweighs the value gained, so the 2025 calendar publication will be our last. We will continue with the recently introduced charity Christmas card sales as they provide valuable income and useful publicity.
The cancer support group (Coffee Connections) formed in Newbury in 2023 goes from strength to strength with an average of 15 attendees (with a recent peak of 20) every Monday at a local community café. In early 2025, a new lunch club was introduced, primarily aimed at those who cannot regularly attend the coffee morning due to work commitments.
To mark the 40th anniversary of the founding of Newbury Cancer Care we held a celebratory event in May 2024 at a local hotel, which was attended by almost 90 guests. We were able to provide a summary of our history and achievements via presentations and files of press cuttings and photographs over the years. It was also an opportunity to thank the many funders, volunteers and staff who have supported the charity over this period and to outline our exciting plans for the future.
In June 2024 we held a seminar for local healthcare professionals working in the spheres of cancer care and supporting services. Entitled “Cancer Care in the Community, Towards the Future” over 70 attendees heard presentations from local, regional and national speakers on subjects ranging from end of life care, cancer survival statistics, lung cancer treatments, living with constant neuropathic pain and the development of the NHS and the challenges the organisation faces. Feedback from attendees was very positive.
A number of side rooms in one of the wards within the West Berkshire Community Hospital (WBCH) are in almost constant use as palliative care and end-of-life facilities. We have agreed to fund the installation of patio doors in a number of these rooms which will provide access to a new low maintenance garden, and the first two sets of these doors were installed in mid 2025. These newly configured rooms are termed “Butterfly Rooms”.
The series of “Take Control” and “Wellbeing” days held in the Rosemary Centre in conjunction with the RBH Cancer Rehab Team, proved very popular. On the back of this success, additional workshops entitled “Coping Creatively” and also Chair Yoga sessions have commenced in 2025.
Newbury Cancer Care core objectives continue to be:
-
Providing support and advice
-
Patient transport services
-
Patient hardship grants
-
Providing equipment as and when requested
-
Clinical staff educational support
-
Support of the Rainbow Rooms and Rosemary Centre services
Page 4
Newbury Cancer Care
Trustees' Report (continued)
Financial review
Income from the Charity's core activity for the year ended 31 December 2024 amounted to £261,649 (2023: £187,297) comprising £165,682 (2023: £156,169) from the various donations and local community fundraising initiatives, legacy receipts of £73,875 (2023: £16,848), the sale of calendars, books and Christmas cards of £6,735 (2023: £6,935) and investment income of £15,357 (2023: £7,345).
Unrestricted direct expenses of £82,269 (2023: £100,064) include patient grants of £36,110 (2023: £44,595) transport service and coordinator costs of £45,581 (2023: £38,089), support grants are nil compared to (2023: £5,500) and expenditure on Rainbow Rooms equipment and expenses of £578 (2023: £11,880) . A further £105,607 (2023: £88,098) has been expended on overhead and support costs. £4,762 has been expended on fundraising costs (2023: £5,453). There is a resultant surplus on income over expenditure on the charity's core activity of £69,011 (2023: Deficit £6,318).
The Charity's share of the Rosemary Appeal Income for the year ended 31 December 2024 amounted to £500,000 (2023: nil). Expenditure from this fund amounted to £393. (2023: £29,357) These funds are held on a restricted basis.
The overall effect of combining the Charity's core activity with the Rosemary Appeal funding leaves a surplus of £568,618 (2023: Deficit £35,675) resulting in an increase in reserves to £1,058,088 (2023: £489,470) of which £707,523 (2023: £207,916) is restricted and £350,565 (2023: £281,554) in unrestricted.
Page 5
Newbury Cancer Care
Trustees' Report (continued)
Plans for future periods
Aims and key objectives for future periods
We have agreed to provide funding to extend the current chemotherapy chair service in the Rosemary Centre from the current facility which has 4 chairs used 2 days per week. The funding includes any changes to the internal building structure to accommodate the extra space required, purchase of an additional 4 chairs and an increase in staffing levels (funding for 12 months) to build up to a full 5-day service – ultimately leading to a five-fold increase in capacity. The RBH business case to cover the increase in lease costs and the legal costs associated with this change has been approved and the NHS Estates Dept have been contracted to provide a design and project management service. The extended service is expected to be in place by the end of 2025.
The Financial review shows a large surplus of income over expenditure for the 2024 financial year, almost entirely due to a large legacy received during the year. This legacy was given with the proviso that it be used exclusively for projects in or on the Rosemary Centre – i.e. a Restricted donation. The Trustees consider that this large donation should be used to cover the costs associated with the above chemo chairs extension project and the project described below regarding additional/extended cancer care services in the reconfigured Rosemary Centre day-room.
The lease for the main Rosemary Centre day-room space has been held by Sue Ryder since opening in 2018 but, post-COVID, has been under-utilised. With the move by Sue Ryder to centralise their administration function to another Berkshire location, we have been able to work with Sue Ryder and the cancer centre at the Royal Berkshire Hospital (RBH) to develop plans for more extensive use of the day-room space. Initial drawings of the reconfigured space show the creation of 3 consulting rooms, 2 treatment rooms, admin space, an improved reception area and a flexibly configured meeting/workshop room. These plans will be developed for work to commence in 2026.
The start made on turning Donnington Ward side rooms to “Butterfly Rooms” will continue with the creation of a low maintenance garden and, potentially, further patio doors installations. The timescale for these works will depend on room utilisation and in conjunction with the requirements of the ward staff.
The building to house two MRI scanners and two PET scanners as part of the WBCH’s role as a Government Diagnostic Centre has been delayed from its anticipated 2024 build. We still expect these new diagnostic facilities to provide opportunities for Newbury Cancer Care to provide support for service enhancements.
We thank those Trustees who have recently stood down from their role and welcome the newly appointed Trustees. We will continue to seek new Trustees with relevant experience and knowledge and a passion for supporting cancer patients and their families throughout West Berkshire.
Structure, governance and management
Nature of governing document
The Newbury and District Cancer Care Trust (NDCCT) was established as a Charitable Unincorporated Association Registered Charity No. 291975. On 1 October 2014 the NDCCT converted to a Charitable Incorporated Organisation (CIO) registration no. 1157796 and transferred the net assets into this entity. During the period ended 31 December 2018 NDCCT changed its name, corporate colours and logo to Newbury Cancer Care.
Recruitment and appointment of trustees
When a vacancy occurs the remaining Trustees are responsible for the identification and appointment of suitable replacements. New Trustees are briefed on governance issues, responsibilities of the office of Charity Trustee and are familiarised with administrative procedures and the core objectives of the Charity.
Page 6
Newbury Cancer Care
Trustees' Report (continued)
Arrangements for setting key management personnel remuneration
The remuneration of key management is set by the board of Trustees.
Organisational structure
Decisions are made by the board of Trustees, and are carried out by the Charity's Director of Operations, Ms Helen Milroy, and one transport co-ordinator.
Major risks and management of those risks
Risk management
Throughout 2024 we continued to monitor the risks included in the Risk Register (developed in 2021) and, in line with our Risk Management Policy (updated in 2021), take any remedial/mitigating actions as necessary.
Total unrestricted reserves are considered sufficient to cover one year of routine fixed expenditure and allow the charity to continue to fulfil its core objectives. As core costs increase, the charity will review any unrestricted surplus to assess if it is viable for the Reserves to be increased to continue to cover one year of routine fixed expenditure thus allowing the charity to continue to fulfil its core objectives.
The annual report was approved by the trustees of the charity on .................... and signed on its behalf by:
......................................... D I Ormrod Chairman and trustee
Page 7
Newbury Cancer Care
Statement of Trustees' Responsibilities
The trustees are responsible for preparing the trustees' report and the financial statements in accordance with the United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) and applicable law and regulations.
The law applicable to charities requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charities (Accounts and Reports) Regulations 2008, and the provisions of the constitution. The trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Approved by the trustees of the charity on .................... and signed on its behalf by:
......................................... D I Ormrod Chairman and trustee
Page 8
Newbury Cancer Care
Independent Examiner's Report to the trustees of Newbury Cancer Care
I report to the trustees on my examination of the accounts of Newbury Cancer Care for the year ended 31 December 2024.
Responsibilities and basis of report
As the charity trustees of Newbury Cancer Care you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the Newbury Cancer Care's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner’s statement
Since Newbury Cancer Care's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of Newbury Cancer Care as required by section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view' which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
...................................... Kerry Hawkins, FCCA Chartered Accountants and Registered Auditors UHY Ross Brooke
31a Charnham Street Hungerford Berkshire RG17 0EJ
Date:.............................
Page 9
Newbury Cancer Care
Statement of Financial Activities for the Year Ended 31 December 2024
| Unrestricted Total |
|
|---|---|
| funds Restricted funds 2024 |
|
| Note | £ £ £ |
| Income and Endowments from: | |
| Donations and legacies 2 |
239,557 500,000 739,557 |
| Other trading activities 3 |
6,735 - 6,735 |
| Investment income 4 |
15,357 - 15,357 |
| Total income | |
| 261,649 500,000 761,649 |
|
| Expenditure on: | |
| Fundraising costs | (4,762) - (4,762) |
| Direct costs 6 |
(82,269) (393) (82,662) |
| Independent Examiner’s remuneration 5 |
(2,000) - (2,000) |
| Other governance costs 5 |
(1,103) - (1,103) |
| Support costs 7 |
(102,504) - (102,504) |
| Total expenditure | |
| (192,638) (393) (193,031) |
|
| Net income | |
| 69,011 499,607 568,618 |
|
| Net movement in funds | |
| 69,011 499,607 568,618 |
|
| Reconciliation of funds | |
| Total funds brought forward | |
| 281,554 207,916 489,470 |
|
| Total funds carried forward 16 |
|
| 350,565 707,523 1,058,088 |
The notes on pages 13 to 23 form an integral part of these financial statements. Page 10
Newbury Cancer Care
Statement of Financial Activities for the Year Ended 31 December 2024 (continued)
| Unrestricted | |
|---|---|
| funds Restricted funds Total |
|
| 2023 2023 2023 |
|
| Note | £ £ £ |
| Income and Endowments from: | |
| Donations and legacies 2 |
173,017 - 173,017 |
| Other trading activities 3 |
6,935 - 6,935 |
| Investment income 4 |
7,345 - 7,345 |
| Total income | |
| 187,297 - 187,297 |
|
| Expenditure on: | |
| Raising funds | (5,453) - (5,453) |
| Direct costs 6 |
(100,064) (29,357) (129,421) |
| Independent Examiner’s remuneration 5 |
(2,000) - (2,000) |
| Other governance costs 5 |
(812) - (812) |
| Other expenditure 7 |
(85,286) - (85,286) |
| Total expenditure | |
| (193,615) (29,357) (222,972) |
|
| Net expenditure | |
| (6,318) (29,357) (35,675) |
|
| Net movement in funds | |
| (6,318) (29,357) (35,675) |
|
| Reconciliation of funds | |
| Total funds brought forward | |
| 287,872 237,273 525,145 |
|
| Total funds carried forward 16 |
|
| 281,554 207,916 489,470 |
All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2023 is shown in note 16.
The notes on pages 13 to 23 form an integral part of these financial statements. Page 11
Newbury Cancer Care
(Registration number: 1157796) Balance Sheet as at 31 December 2024
| 2024 2023 |
|
|---|---|
| Note | £ £ |
| Fixed assets | |
| Tangible assets 12 |
415 409 |
| Current assets | |
| Debtors 13 |
24,992 27,335 |
| Cash at bank and in hand 14 |
1,037,271 477,055 |
| 1,062,263 504,390 |
|
| Creditors: Amounts falling due within oneyear 15 |
|
| (4,590) (15,329) |
|
| Net currentassets | |
| 1,057,673 489,061 |
|
| Netassets | |
| 1,058,088 489,470 |
|
| Funds of the charity: | |
| Restricted income funds | |
| Restricted funds 16 |
707,523 207,916 |
| Unrestricted income funds | |
| Unrestricted funds | 350,565 281,554 |
| Total funds 16 |
|
| 1,058,088 489,470 |
The financial statements on pages 10 to 23 were approved by the trustees, and authorised for issue on .................... and signed on their behalf by:
......................................... D I Ormrod Chairman and trustee
The notes on pages 13 to 23 form an integral part of these financial statements. Page 12
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024
1 Accounting policies
Statement of compliance
The financial statements have been prepared in accordance with the second edition of the Charities Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011.
Basis of preparation
Newbury Cancer Care meets the definition of a public benefit entity under FRS 102. The accounts (financial statements) have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts.
Going concern
The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern.
Income and endowments
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
The recognition of income from legacies is dependant on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the charity has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the charity, can be reliably measured.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
General donations are accounted for on a cash received basis. Donations and gifts in kind are included in the financial statements at market value.
Income from calendars and functions is included when the charity has entitlement to receive it.
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity: this is normally upon notification of the interest paid or payable by the bank.
The Rosemary Appeal was a joint appeal with Newbury and Thatcham Hospital Building Trust. The purpose of the appeal was to build a purpose built building offering both bespoke care for cancer patients (on top floor) and those with renal failure (on ground floor). The building was opened in 2018. The income and expenditure for this appeal is split equally between the two charities. All income and expenditure is restricted for this project.
Page 13
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
Expenditure
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs.
Raising funds
These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.
Charitable activities
Charitable expenditure, direct costs and support costs comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.
Grant expenditure
Grants payable are charged in the period when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the period end are noted as a commitment, but not accrued as expenditure.
Governance costs
These include the costs attributable to the charity’s compliance with constitutional and statutory requirements, including audit, strategic management and trustees meetings and reimbursed expenses.
Tangible fixed assets
Individual fixed assets costing £500.00 or more are initially recorded at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation and amortisation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
| Asset class | Depreciation method and rate |
|---|---|
| Office Equipment | 20% straight line |
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Page 14
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
Trade creditors
are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the charity does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Fund structure
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
Investment income, gains and losses are allocated to the appropriate fund.
Pensions
The charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the charity to the fund in respect of the period.
2 Income from donations and legacies
| Unrestricted | |
|---|---|
| funds Restricted Total Total |
|
| General funds 2024 2023 |
|
| £ £ £ £ |
|
| Donations | 165,682 - 165,682 156,169 |
| Legacies | 73,875 - 73,875 16,848 |
| RosemaryAppeal | - 500,000 500,000 - |
| 239,557 500,000 739,557 173,017 |
Page 15
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
3 Income from other trading activities
| 3 Income from other trading activities |
3 Income from other trading activities |
|---|---|
| Unrestricted | |
| funds Total Total |
|
| General 2024 2023 |
|
| £ £ £ |
|
| Trading income; | |
| Calendar sales 6,390 6,390 6,588 |
|
| Christmas card sales 345 345 347 |
|
| 6,735 6,735 6,935 |
|
| 4 Investment income |
|
| Unrestricted | |
| funds Total |
|
| General funds |
|
| £ £ |
|
| Investment income 15,357 15,357 |
|
| Total for 2024 15,357 15,357 |
|
| Total for 2023 7,345 7,345 |
|
| 5 Other governance costs |
|
| Unrestricted | |
| funds Total Total |
|
| General 2024 2023 |
|
| £ £ £ |
|
| Independent Examiner’s remuneration 2,000 2,000 2,000 |
|
| Othergovernance costs 1,103 1,103 812 |
|
| 3,103 3,103 2,812 |
|
| 6 Direct costs |
|
| 2024 2023 |
|
| £ £ |
|
| Rosemary Appeal (Restricted Funds) | 393 29,357 |
| Patient transport costs | 24,050 17,185 |
| Grants to institutions | - 5,500 |
| Rainbow Rooms equipment and expenses | 578 11,880 |
| Grants to individuals | 36,110 44,595 |
| Wages and salaries | 21,531 20,904 |
| Direct costs total | |
| 82,662 129,421 |
Page 16
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
7 Support costs
| 7 Support costs |
|
|---|---|
| Unrestricted | |
| funds Total |
|
| General 2024 |
|
| £ £ |
|
| Staff costs | |
| Wages and salaries | 34,608 34,608 |
| Pension costs | 1,310 1,310 |
| Office Travel | 519 519 |
| Rent | 1,263 1,263 |
| Insurance | 804 804 |
| Repairs and maintenance | 138 138 |
| Marketing | 13,689 13,689 |
| Telephone and fax | 1,891 1,891 |
| IT expenses | 2,927 2,927 |
| Printing, postage and stationery | 1,721 1,721 |
| Sundry expenses | 550 550 |
| Support services - support costs | 2,191 2,191 |
| SALT Support funding - support costs | 32,376 32,376 |
| Training | 7,850 7,850 |
| Just giving charges | 563 563 |
| Depreciation of computer | 104 104 |
| 102,504 102,504 |
Page 17
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
| Unrestricted | ||
|---|---|---|
| funds | Total | |
| General | 2023 | |
| £ | £ | |
| Staff costs | ||
| Wages and salaries | 33,600 | 33,600 |
| Pension costs | 1,261 | 1,261 |
| Office Travel | 415 | 415 |
| Rent | 1,215 | 1,215 |
| Insurance | 860 | 860 |
| Repairs and maintenance | 200 | 200 |
| Marketing | 9,965 | 9,965 |
| Telephone and fax | 1,620 | 1,620 |
| IT expenses | 2,614 | 2,614 |
| Printing, postage and stationery | 572 | 572 |
| Sundry expenses | 329 | 329 |
| Support services - support costs | 1,137 | 1,137 |
| SALT Support funding - support costs | 30,834 | 30,834 |
| Just giving charges | 562 | 562 |
| Depreciation of computer | 102 | 102 |
| 85,286 | 85,286 |
8 Grant-making
Analysis of grants
| Analysis of grants | ||
|---|---|---|
| Grants | to | |
| institutions | ||
| 2023 | ||
| £ | ||
| Analysis | ||
| MyCancer MyChoice | 5,500 |
9 Trustees remuneration and expenses
No trustees, nor any persons connected with them, have received any remuneration from the charity during the year in relation to their trustee duties.
One trustee was also a service user and received a hardship grant awarded in line with our policies.
No trustees have received any reimbursed expenses from the charity during the year.
Page 18
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
10 Staff costs
The aggregate payroll costs were as follows:
| The aggregate payroll costs were as follows: | |
|---|---|
| 2024 2023 |
|
| £ £ |
|
| Staff costs during the year were: | |
| Wages and salaries | 56,139 54,504 |
| Employerspension | 1,310 1,261 |
| 57,449 55,765 |
The monthly average number of persons (including senior management / leadership team) employed by the charity during the year expressed as full time equivalents was as follows:
| charity during the year expressed as full time equivalents was as follows: | |
|---|---|
| 2024 2023 |
|
| No No |
|
| Average number of employees - all part time | 2 2 |
Contributions to the employee pension schemes for the year totalled £1,310 (2023 - £1,261). As at the end of the year £255 was unpaid.
No employee received emoluments of more than £60,000 during the year
Page 19
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
11 Taxation
The charity is a registered charity and is therefore exempt from taxation.
12 Tangible fixed assets
| 12 Tangible fixed assets |
|
|---|---|
| Office Total |
|
| Equipment£ £ |
|
| Cost | |
| At 1 January 2024 | 4,078 4,078 |
| Additions | 110 110 |
| At 31 December 2024 | 4,188 4,188 |
| Depreciation | |
| At 1 January 2024 | 3,669 3,669 |
| Charge for theyear | 104 104 |
| At 31 December 2024 | 3,773 3,773 |
| Net book value | |
| At 31 December 2024 | 415 415 |
| At 31 December 2023 | 409 409 |
| 13 Debtors |
|
| 2024 2023 |
|
| £ £ |
|
| Rosemary Appeal - NTHBT | 11,392 11,392 |
| Prepayments | 924 3,450 |
| Other debtors | 5,262 8,189 |
| Gift Aid control | 7,414 4,304 |
| 24,992 27,335 |
|
| 14 Cash and cash equivalents |
|
| 2024 2023 |
|
| £ £ |
|
| Cash at bank | 1,037,271 477,055 |
Page 20
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
| 15 Creditors: amounts falling due within one year |
||||
|---|---|---|---|---|
| 2024 | 2023 | |||
| £ | £ | |||
| Trade creditors | 523 | 911 | ||
| Other taxation and social security | 723 | - | ||
| Other creditors | 669 | 11,918 | ||
| Accruals | 2,675 | 2,500 | ||
| 4,590 | 15,329 |
16 Funds
| 16 Funds |
|
|---|---|
| Balance at 1 Incoming Resources Balance at 31 |
|
| January 2024 resources expended December 2024 |
|
£ £ £ £ |
|
| Unrestricted funds | |
| General | |
| General Funds - all funds | 281,554 245,656 (192,060) 335,150 |
| Designated | |
| Rainbow Rooms | - 15,993 (578) 15,415 |
| Total unrestricted funds | |
| 281,554 261,649 (192,638) 350,565 |
|
| Restricted funds | |
| RosemaryAppeal | 207,916 500,000 (393) 707,523 |
| Total funds | |
| 489,470 761,649 (193,031) 1,058,088 |
Page 21
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
| Balance at 1 Incoming Resources Balance at 31 December |
|
|---|---|
| January 2023 resources expended Transfers 2023 |
|
£ £ £ £ £ |
|
| Unrestricted funds | |
| General | |
| General Funds - all funds | 287,872 182,993 (181,735) (7,576) 281,554 |
| Designated | |
| Rainbow Rooms | - 4,304 (11,880) 7,576 - |
| Total unrestricted funds | |
| 287,872 187,297 (193,615) - 281,554 |
|
| Restricted | |
| RosemaryAppeal | 237,273 - (29,357) - 207,916 |
| Total funds | |
| 525,145 187,297 (222,972) - 489,470 |
The specific purposes for which the funds are to be applied are as follows:
Designated funds
The Rainbow Rooms provide facilities combining the comfort of a private room with connecting doors to an adjoining family room, to allow family members to stay at the hospital with their loved one who is at the end stage of life.
Restricted funds
The Rosemary Appeal was a joint project with the Newbury & Thatcham Hospital Building Trust (N&THBT), to provide a building to provide essential facilities for the local community, including chemotherapy, IV therapies, day care, renal dialysis.
17 Analysis of net assets between funds
| 17 Analysis of net assets between funds |
|
|---|---|
| Unrestricted Total funds at 31 |
|
| funds Restricted December |
|
| General funds 2024 |
|
| £ £ £ |
|
| Tangible fixed assets | 415 - 415 |
| Current assets | 354,740 707,523 1,062,263 |
| Current liabilities | (4,590) - (4,590) |
| Total net assets | |
| 350,565 707,523 1,058,088 |
Page 22
Newbury Cancer Care
Notes to the Financial Statements for the Year Ended 31 December 2024 (continued)
| Unrestricted | Total funds at 31 | ||
|---|---|---|---|
| funds | Restricted | December | |
| General | funds | ||
| 2023 | 2023 | 2023 | |
| £ | £ | £ | |
| Tangible fixed assets | 409 | - | 409 |
| Current assets | 296,474 | 207,916 | 504,390 |
| Current liabilities | (15,329) | - | (15,329) |
| Total net assets | 281,554 | 207,916 | 489,470 |
18 Related party transactions
There were no related party transactions in the year.
Page 23